Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06833229 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prospective Cohort Study Evaluating 18FDG PET-CT for the Early Prediction of the Efficacy of Immunotherapy Associated or Not With Chemotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Broncho-Pulmonary Carcinoma

Study acronym: FDG Immun Comb
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv3
  2. Primary completion date: Jan 27, 2029 to May 27, 2028v2 Show 4 more changesShow less
    • Study completion date: Jan 27, 2029 to Jan 27, 2031
    • Secondary endpoints: details revised at 1 of 4 entries
    • Study title revised
    • Eligibility criteria expanded, about 2 words
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The hypothesis of this prospective observational pilot study of diagnostic diagnostic performance is that, for patients with NSCLC treated with immunotherapy associated or not with chemotherapy, certain metabolic biomarkers on 18FDG PET scans allow early identification of treatment response (or lack of response to treatment) and optimize prediction of tumor response compared with current standards.
Trial Details
NCT Number NCT06833229
Lead Sponsor Centre Antoine Lacassagne
Conditions
(from sponsor)		 Carcinoma, Non-Small-Cell Lung (NSCLC)
Related terms Carcinoma, Carcinoma, Non-Small-Cell Lung
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov